Downtrend on the daily chart: below its 50- and 200-day averages · 50-day above the 200-day · SuperTrend down since Sep 30 · below the Ichimoku cloud · RSI 35 · MACD below its signal
None of the 29 investors followed here reported a position in OSTX in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a OSTX trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| May 6, 2025 | Auerbach ShalomBeneficial Owner of more than 10% of a Class of Security | Sale at price 2.00 per share. | 82K | $163.92K |
| Feb 13, 2025 | Auerbach ShalomBeneficial Owner of more than 10% of a Class of Security | Sale at price 2.23 per share. | 100K | $223.00K |
| Jan 14, 2025 | Auerbach ShalomBeneficial Owner of more than 10% of a Class of Security | Sale at price 4.36 per share. | 16.7K | $72.90K |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -2.9 | 8.1 | -4.1 | 20.6 | 25.9 | -11.2 | -20.0 | 11.2 | -5.3 | -10.9 | +1.8% | ||
| 2025 | -57.0 | -10.3 | -6.7 | 31.8 | -24.6 | 22.9 | -5.3 | 34.3 | -18.0 | -5.1 | -3.8 | -21.8 | −67.3% |
| 2024 | -32.4 | -6.4 | -18.3 | 100.0 | +3.4% |
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. The company's pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. The company was incorporated in 2018 and is based in Grasonville, Maryland.
Buy / hold / sell counts